Strong Revenue Growth:
A stated milestone of surpassing $100M in contracted annual recurring revenue by end‑2025 and placement on Deloitte’s Technology Fast 500 point to multi‑year top‑line momentum. These indicators align with expanding utilization metrics such as billions of annual patient communications.
Investor Backing & Capital Strength:
A $65M growth investment announced in December 2025 is positioned to fund expansion and accelerate AI initiatives. This capital raise underscores confidence from investors in the company’s scaling trajectory.
Strategic Partnerships:
Embedded distribution via MEDITECH’s Expanse Patient Connect being powered by the platform and Oracle Health roadmap references extend reach within major EHR ecosystems. These integrations provide channel access and stickiness in enterprise workflows.
.jpg)
.jpg)
